Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Synthesis, radiolabeling, and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy.

De K, Bhowmik A, Behera A, Banerjee I, Ghosh MK, Misra M.

J Pept Sci. 2012 Oct 26. doi: 10.1002/psc.2458. [Epub ahead of print]

PMID:
23109400
[PubMed - as supplied by publisher]
2.

Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors.

Gandomkar M, Najafi R, Shafiei M, Mazidi M, Ebrahimi SE.

Nucl Med Biol. 2007 Aug;34(6):651-7.

PMID:
17707805
[PubMed - indexed for MEDLINE]
3.
4.

Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.

Erfani M, Shafiei M, Mazidi M, Goudarzi M.

Cancer Biother Radiopharm. 2013 Apr;28(3):240-7. doi: 10.1089/cbr.2012.1270. Epub 2013 Mar 6.

PMID:
23464855
[PubMed - indexed for MEDLINE]
5.

(99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.

Dong C, Zhao H, Yang S, Shi J, Huang J, Cui L, Zhong L, Jin X, Li F, Liu Z, Jia B, Wang F.

Mol Pharm. 2013 Aug 5;10(8):2925-33. doi: 10.1021/mp400040z. Epub 2013 Jun 28.

PMID:
23768172
[PubMed - indexed for MEDLINE]
6.

Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.

Behera A, Banerjee I, De K, Munda RN, Chattopadhayay S, Samanta A, Sarkar B, Ganguly S, Misra M.

Amino Acids. 2013 Mar;44(3):933-46. doi: 10.1007/s00726-012-1423-7. Epub 2012 Oct 23.

PMID:
23090293
[PubMed - indexed for MEDLINE]
7.

Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.

Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.

Chin Med J (Engl). 2012 Jul;125(14):2538-42.

PMID:
22882936
[PubMed - indexed for MEDLINE]
Free Article
8.

Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.

Li Y, Si JM, Zhang J, Du J, Wang F, Jia B.

World J Gastroenterol. 2005 Jul 7;11(25):3953-7.

PMID:
15991301
[PubMed - indexed for MEDLINE]
Free Article
9.

[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.

Maina T, Nock BA, Cordopatis P, Bernard BF, Breeman WA, van Gameren A, van den Berg R, Reubi JC, Krenning EP, de Jong M.

Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):831-40. Epub 2006 Mar 28.

PMID:
16568203
[PubMed - indexed for MEDLINE]
10.

Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.

Bangard M, Béhé M, Guhlke S, Otte R, Bender H, Maecke HR, Biersack HJ.

Eur J Nucl Med. 2000 Jun;27(6):628-37.

PMID:
10901448
[PubMed - indexed for MEDLINE]
11.

99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.

Decristoforo C, Melendez-Alafort L, Sosabowski JK, Mather SJ.

J Nucl Med. 2000 Jun;41(6):1114-9.

PMID:
10855644
[PubMed - indexed for MEDLINE]
Free Article
12.

Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.

Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ.

Nucl Med Biol. 2008 May;35(4):401-11. doi: 10.1016/j.nucmedbio.2008.02.005.

PMID:
18482677
[PubMed - indexed for MEDLINE]
13.

Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.

Kosowicz J, Mikołajczak R, Czepczyński R, Ziemnicka K, Gryczyńska M, Sowiński J.

Cancer Biother Radiopharm. 2007 Oct;22(5):613-28.

PMID:
17979564
[PubMed - indexed for MEDLINE]
14.

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.

von Guggenberg E, Dietrich H, Skvortsova I, Gabriel M, Virgolini IJ, Decristoforo C.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1209-18. Epub 2007 Feb 17.

PMID:
17308920
[PubMed - indexed for MEDLINE]
15.

Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.

Decristoforo C, Mather SJ.

Eur J Nucl Med. 1999 Aug;26(8):869-76.

PMID:
10436200
[PubMed - indexed for MEDLINE]
16.

Experience with indium-111 and yttrium-90-labeled somatostatin analogs.

Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.

Curr Pharm Des. 2002;8(20):1781-807. Review.

PMID:
12171531
[PubMed - indexed for MEDLINE]
17.

An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.

Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, Moncayo R.

J Nucl Med. 2003 May;44(5):708-16.

PMID:
12732671
[PubMed - indexed for MEDLINE]
Free Article
18.

99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.

von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.

Bioconjug Chem. 2004 Jul-Aug;15(4):864-71.

PMID:
15264875
[PubMed - indexed for MEDLINE]
19.

A (99m) Tc-tricine-HYNIC-labeled peptide targeting the neurotensin receptor for single-photon imaging in malignant tumors.

Erfani M, Zarrabi Ahrabi N, Shafiei M, Shirmardi SP.

J Labelled Comp Radiopharm. 2014 Mar;57(3):125-31. doi: 10.1002/jlcr.3176. Epub 2014 Jan 7.

PMID:
24395489
[PubMed - in process]
20.

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.

Wild D, Schmitt JS, Ginj M, Mäcke HR, Bernard BF, Krenning E, De Jong M, Wenger S, Reubi JC.

Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1338-47. Epub 2003 Aug 21.

PMID:
12937948
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk